Diabetes patients on dulaglutide (Trulicity) had better glycemic control and more weight loss if they switched to tirzepatide ...

The study finds better A1c lowering and weight reduction, but an expert clinician says practical issues may pose barriers.

Zepbound (tirzepatide) is a brand-name drug prescribed ... When receiving Zepbound, always follow the dosage prescribed by your doctor. Zepbound comes as a solution that’s given as a ...

A new analysis of FDA adverse event reports suggests a potential link between tirzepatide and thyroid cancer. Learn what this ...

While real-world Tirzepatide dose escalations were slower than those observed during the drug's clinical trials, with many patients remaining on lower doses such as 5 mg or 7.5 mg even after six ...

It is not sold by Eli Lilly in any oral format. Lexaria's Study was designed to discover whether the active drug within Zepbound® - tirzepatide - could be administered using Lexaria's patented ...

The trial examined the effect of Eli Lilly’s glucagon-like peptide-1 receptor agonist (GLP-1RA) tirzepatide ... Patients were on a starting dose of 2.5mg/week, which was uptitrated by 2.5mg ...